Shay Capital LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1723643 NEW YORK, NY

Back to TMO Full portfolio

Position in TMO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$15,942,775

+$15,653,050 QoQ

Shares Held

32,435

+6387.0% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

2.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Derivatives in TMO

reported options exposure · as of Mar 31, 2026

CallValue

$2,703,415

CallShares

5,500

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Shay Capital LLC holds $17,996,361 across 3 Diagnostics & Research names. TMO ranks #1 (88.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc. This page	32,435	$15,942,775
2	QGEN	Qiagen N.V.	42,672	$1,708,586
3	MDXH	MDxHealth SA	150,000	$345,000

All Filings in TMO

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,703,415	5,500	-83.0%	Call	Sole	2026-05-15
2026-03-31	$15,942,775	32,435	+6387.0%	Shares	Sole	2026-05-15
2025-12-31	$289,725	500	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.